Avaxim 160 Unit (Hepatitis a Virus, Inactivated) Suspension

AVAXIM 160 Unit is a hepatitis A vaccine designed to protect against hepatitis A virus infection. This inactivated vaccine is administered intramuscularly and is suitable for individuals seeking immunity.

AVAXIM 160 Unit is used to prevent hepatitis A, a viral infection that can cause liver inflammation. It is typically recommended for individuals traveling to regions with high hepatitis A prevalence or those at increased risk of exposure. The vaccine works by stimulating the body's immune response to develop protection against the virus.

Common effects of AVAXIM 160 Unit may include mild soreness, redness, or swelling at the injection site. Some individuals might experience temporary fatigue, headache, or low-grade fever. These effects are generally mild and short-lived.

AVAXIM 160 Unit should be stored as directed to maintain its efficacy. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. Individuals with severe allergies to vaccine components should avoid this product.

AVAXIM 160 Unit may interact with certain medications or other vaccines. It is advisable to discuss current medications with a healthcare provider before receiving the vaccine. Alcohol and other immune-suppressing substances might affect the vaccine's effectiveness.